Brighton, MA, United States of America

Adrian M Lowe

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian M. Lowe

Introduction

Adrian M. Lowe, an accomplished inventor based in Brighton, MA, has made significant contributions to the field of antibacterial research. With a total of five patents to his name, Lowe's work focuses on innovative polypeptides and polynucleotides that have the potential to advance medical science.

Latest Patents

Among his notable inventions, Lowe's latest patents include developments related to ribosome recycling factors and essential bacterial ligases. The first invention addresses the ribosome recycling factor (FRR) of Staphylococcus aureus, providing frr polypeptides and polynucleotides which can be utilized to screen for effective antibacterial compounds. His second patent pertains to the UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of Staphylococcus aureus, which offers methods for producing murD polypeptides, with applications for screening antibacterial agents.

Career Highlights

Adrian M. Lowe has had a notable career, with experience working at various prominent companies such as SmithKline Beecham Corporation. His innovative spirit has led to developments that hold the potential for significant advancements in antibacterial treatments.

Collaborations

Lowe's collaborative work has been enriched by his partnerships with talented individuals in the industry. He has worked alongside colleagues such as Leslie Marie Palmer and Michael Arthur Lonetto, contributing to the collective advancement of antibacterial research.

Conclusion

Adrian M. Lowe's dedication to innovation and his contributions to the field of antibacterial research through his patents exemplify the impact of inventive minds on modern science. His work continues to inspire future advancements in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…